MDB stock is trading near $326.13 after a 28% rally in the past month — we rate MongoDB a Buy with a $368.67 12-month average analyst price target and material upside if Q1 FY27 earnings on May 28, 2026 confirm the Atlas reacceleration. The setup pairs an oversold tape (still down ~18% year-to-date) with a Wall Street consensus of 33 Buy ratings, BofA at $375, BMO at $360, and a high target of $500 from Citi. Risk-reward favours bulls into the print, provided Atlas growth holds the 26%+ line and FY27 guidance does not get cut a second time.
| Key Stock Data | Value |
|---|---|
| Current Price | ~$326.13 |
| 52-Week Range | $140 – $370 |
| Market Cap | ~$26.5 billion |
| P/S Ratio (TTM) | 10.6x |
| FY26 Revenue | $2.46 billion (+22.8% YoY) |
| Adj. EPS (Q1 FY26 last reported) | $1.00 (beat $0.66 est.) |
| Analyst Consensus | Buy (33 analysts) |
| Average Price Target | $368.67 |
| High / Low Target | $500 / $260 |
| Next Earnings | May 28, 2026 (Q1 FY27) |
Table of Contents
- MDB Stock Snapshot — Key Takeaways
- What MongoDB Does and Why MDB Stock Matters
- MDB Stock Recent Price Performance
- MDB Stock Valuation Analysis
- Q1 FY27 Setup, Atlas, and AI Catalysts for MDB Stock
- Bullish and Bearish Analyst Opinions on MongoDB
- MDB Stock Analyst Price Targets and 12-Month Outlook
- MDB Stock Risks Investors Should Not Ignore
- MDB Stock FAQs
MDB Stock Snapshot — Key Takeaways
- Price and verdict: MDB stock trades near $326.13 with a Buy rating and a $368.67 consensus price target — about 13% upside before the May 28 earnings catalyst.
- Key stat: Atlas now contributes 72% of total revenue and grew 26% year-over-year last quarter, the cleanest read-through on AI-native workload demand.
- Bull case: Citi’s $450 target and a “90-day catalyst watch” rest on AI-native customer ramp, 71.8% gross margins, and $178.5M of free cash flow in the most recent quarter.
- Bear case: Baird cut the target from $500 to $260 and downgraded to Neutral after cautious FY27 guidance; growth deceleration and CRO turnover are the bear’s exhibits.
- What to watch May 28: Atlas growth rate, FY27 revenue guidance versus the $2.25B–$2.29B range, and any commentary on AI-native customer spend.
What MongoDB Does and Why MDB Stock Matters
MongoDB (NASDAQ: MDB) operates a general-purpose document database platform used by enterprises to build, scale, and operate modern applications. The flagship offering, MongoDB Atlas, is a fully managed cloud database service that runs across AWS, Azure, and Google Cloud — a posture that makes MDB stock price direct exposure to multi-cloud database spending. Atlas accounted for roughly 72% of Q4 FY26 revenue, with the remainder coming from Enterprise Advanced (self-managed) and professional services.
The reason MDB stock matters now is positioning. The agentic-AI build-out requires databases that can store structured data, vectors, time-series, and operational state in one engine. MongoDB’s flexible document model and 2026 platform updates — automated embeddings, persistent agent memory, cross-region private connectivity — directly target that workload. The company added 2,600 new customers in Q1 FY26 alone, bringing the base over 57,100, and large hyperscaler partnerships have not yet been disrupted by the vector-database upstarts.
For tactical investors, the stock has become a sentiment proxy for “is AI infrastructure spend broadening beyond NVDA stock price and the hyperscalers?” Every Atlas guide gets read as a tell on enterprise AI deployment velocity. That is why a single quarterly print swings MDB stock 14% in either direction — the May 28 release will reset the narrative for the entire data-layer cohort, including Snowflake stock price and Datadog stock price.
MDB Stock Recent Price Performance
The MDB stock chart in 2026 has been a study in two halves. The first quarter delivered the kind of drawdown that ends careers: on March 3, 2026, shares fell roughly 22% in a single session after Q4 FY26 results beat on both revenue and EPS but were paired with cautious FY27 guidance. Year-to-date, MDB stock is down approximately 18.4% by some screens and as much as 41.9% by others depending on the reference price used — the discrepancy itself reflects how violent the March repricing was.
The second half of the picture is the rebound. Over the past month, MDB stock has rallied 28.6%, with a 4.5% gain in the past week alone, as buyers stepped in around the $235–$245 zone and pushed the tape back through the $300 handle. One-year total shareholder return now sits at 75.5%, a reminder that anyone who held through the March panic is sitting on a sizeable gain. The 1-month performance has decisively outpaced the broader software cohort.
Volume profile matters here. The March selloff was driven by a forced repricing — algorithmic mandates that exit on a single guidance disappointment — while the May rebound has been accumulation-led, with institutional buyers re-anchoring positions ahead of the May 28 Q1 FY27 print. Implied volatility ahead of earnings is pricing in a ±14.5% post-print move, the widest setup MongoDB has carried into a report in two years.
The technical picture is constructive but not euphoric. MDB stock has reclaimed both its 50-day and 100-day moving averages and is now testing resistance in the $330–$345 band. A clean breakout above $345 on earnings would put the $370 52-week high in play within weeks; a guide-down repeat would risk a re-test of the $260 Baird target.
MDB Stock Valuation Analysis
Valuing MDB stock is genuinely contentious because MongoDB sits in the awkward zone of “rapid revenue growth, GAAP unprofitable, adjusted profitable.” On a price-to-sales basis, the stock trades at 10.6x trailing revenue versus a US IT industry average closer to 2.2x and a Simply Wall St “fair ratio” estimate of 8.4x. By that lens the stock is expensive.
| Valuation Metric | MDB | Software Peers | Read-through |
|---|---|---|---|
| P/S (TTM) | 10.6x | 8–11x (Snowflake, Datadog) | In line with growth peers, premium to broader IT |
| Forward P/E (Adj.) | ~107x | 50–80x | Premium — earnings growth must accelerate |
| Gross Margin | 71.8% | 70–80% | Elite for an infrastructure platform |
| Q1 FY26 FCF | $178.5M | Mixed | Strongly supports software multiple |
| Current Ratio | 4.7x | 2–3x | Balance sheet flexibility is a real asset |
The bull’s response is straightforward: at 10.6x sales for a 22% top-line grower with elite gross margins and accelerating Atlas consumption, MDB stock is not actually premium — it is fairly priced for the cohort. Simply Wall St’s most-followed narrative pegs fair value at $440, implying 26% upside; consensus DCF work clusters in the $350–$400 zone. Citi’s $450 target is the cleanest articulation of the bull math: assume Atlas grows 28%+ for another year, model 25%+ FCF margins by FY28, and a 12x forward sales multiple gets you north of $450.
The bear’s counter is the multiple-compression risk: if Atlas growth slips to 22% and FY27 guidance gets cut again, the same DCF compresses toward $260. That is the precise Baird target and the gap between bull and bear cases — a 73% spread — is what makes MDB stock a high-conviction position trade rather than a passive buy-and-hold.
Q1 FY27 Setup, Atlas, and AI Catalysts for MDB Stock
The May 28, 2026 print is the entire investment thesis condensed into 90 minutes of conference call. MongoDB will report Q1 FY27 financial results for the three months ended April 30, 2026, with consensus estimates pointing to roughly $553.6M in revenue and $0.66 in adjusted EPS. The prior comparable quarter delivered $549M revenue and $1.00 adjusted EPS — a 49% beat versus the $0.67 estimate at the time.
Three numbers will move MDB stock more than anything else. First, Atlas year-over-year growth: the bull case requires 26%+; below 24% would trigger a re-test of the lows. Second, FY27 revenue guidance — the company’s prior range is $2.25B–$2.29B, and any upward revision would validate the Citi catalyst-watch call. Third, AI-native customer spending commentary; Atlas usage from AI-native customers was the cited reason behind Citi’s $400 → $450 target raise, so directional language matters.
On the platform side, the May 7, 2026 announcement of new AI data-platform capabilities was strategically timed three weeks before earnings. Automated embeddings, persistent agent memory, enhanced database performance, and cross-region private connectivity all target production-grade agentic-AI deployments. If management cites enterprise pipelines tied to these features, the AI-native cohort narrative gets a second wind.
Leadership is the wild card. Ryan Mac Ban joined as Chief Revenue Officer effective April 27, 2026 to lead global sales — the appointment came after sales-leadership departures that spooked the market in March. Investors will parse every comment for evidence the sales motion is intact. A clean sales-execution update would remove one of the bear case’s load-bearing pillars.
Bullish and Bearish Analyst Opinions on MongoDB
The Wall Street debate around MDB stock has rarely been this polarized. Bulls point to Atlas reacceleration, AI-driven demand, and elite cash generation; bears point to growth deceleration, executive turnover, and a forward multiple that requires perfection.
| Bullish Drivers | Bearish Risks |
|---|---|
| Citi raised target to $450 (from $400) — 90-day catalyst watch on AI-native customer ramp | Baird cut target to $260 (from $500), downgraded to Neutral on FY27 guide |
| Atlas +26% YoY, now 72% of revenue — accelerating after March wobble | Atlas grew “only” 29% in Q4 FY26, a slowdown from prior cohort |
| BofA target $375 (up from $350) — believes Atlas usage outpaces guidance | FY27 revenue guide of $2.25B–$2.29B disappointed on revenue and EPS |
| BMO target $360 (up from $285) — credit for management credibility | CRO turnover and securities class-action investigation create headline risk |
| 71.8% gross margin and $178.5M quarterly FCF support premium | P/S of 10.6x is 5x the IT industry average — multiple compression risk |
The most-cited bull is Citi’s note placing MDB stock on an upside catalyst watch after monitoring Atlas usage telemetry from AI-native customers through April. The firm’s $450 target implies 38% upside and is explicitly contingent on the May 28 print validating the consumption signal. BofA’s Koji Ikeda echoed the constructive setup, lifting the target to $375 and arguing the FY27 guide was conservative enough to set up beat-and-raise quarters.
The most cited bear is Baird’s downgrade — a $500 to $260 target cut is the kind of move that typically marks a sentiment trough. The firm’s concern centred on the slight Atlas deceleration to 29% YoY in Q4 FY26 combined with what it called “cautious” FY27 guidance. The bear-side debate is whether $260 is the floor or the next stop. Note that the broader analyst panel still skews bullish: 38% Strong Buy, 47% Buy, 16% Hold, 0% Sell.
MDB Stock Analyst Price Targets and 12-Month Outlook
The 33-analyst consensus on MDB stock now sits at a $368.67 average target, with the high target at $500 (Citi pre-revision; current $450) and the low at $260 (Baird). That implies about 13% upside from the current $326 price, with significantly more leverage if the May 28 print produces a beat-and-raise quarter.
| Firm | Rating | Price Target | Implied Move |
|---|---|---|---|
| Citi | Buy | $450 | +38% |
| BofA (Koji Ikeda) | Buy | $375 | +15% |
| BMO Capital (Keith Bachman) | Outperform | $360 | +10% |
| Consensus (33 analysts) | Buy | $368.67 | +13% |
| Baird | Neutral | $260 | -20% |
The MDB stock price analysis from Simply Wall St’s narrative engine arrives at a $440 fair value (implying 26% undervaluation) using consensus revenue growth, margin expansion, and a tech-style profit multiple. Independent DCF work cited in our earlier MDB stock price analysis coverage points to $350–$400 as the central tendency once Atlas growth normalises to a 24–26% range.
For traders, the actionable read is that the post-earnings move is priced at roughly ±14.5%, which means a $326 stock could close earnings week between $279 and $373 before any directional bias. The asymmetry favours upside because the buy-side has already taken the March guide-down on the chin — a beat-and-raise sets up a multi-month rally; a second guide-down is the bear’s last shot at sub-$300 prints.
MDB Stock Risks Investors Should Not Ignore
Three risk vectors deserve specific attention before sizing a position in MDB stock. First, the legal overhang: MongoDB faces an ongoing securities fraud class action and related governance investigations, both of which create disclosure-driven headline risk through 2026. Even a procedural filing can move shares 3–5% intraday given the post-March sensitivity.
Second, AI-database disruption. Specialized vector databases and agentic-AI primitives are the most-discussed competitive threats. The bull’s response is that MongoDB has bolted vector search into Atlas and added persistent agent memory, but enterprises only need to default to a specialist on one major workload for the share-of-wallet thesis to crack.
Third, share issuance. MongoDB’s share count has crept higher each year through stock-based compensation, structurally diluting per-share metrics. The dilution rate is consistent with software peers but matters more when growth decelerates — a 22% revenue grower can absorb 4–5% annual dilution; a 15% grower cannot. Anyone modelling MDB stock past 2027 needs to stress-test that combination.
MDB Stock FAQs
Is MDB stock a good buy in 2026?
The risk/reward favours bulls at the current $326 print: a 33-analyst Buy consensus, a $368.67 average target, and an upcoming May 28 catalyst that the buy-side has already de-risked. The trade is not a “back up the truck” buy because the Baird downgrade highlights a credible 20% downside scenario if FY27 guidance gets cut again — sizing should reflect the binary nature of the next earnings event.
What is the bullish and bearish analyst opinion on MongoDB right now?
The bullish view, led by Citi at $450 and BofA at $375, rests on Atlas reacceleration to 26%+, AI-native customer expansion, and the platform’s 71.8% gross margins. The bearish view, anchored by Baird at $260, focuses on slight Atlas deceleration in Q4 FY26, FY27 guidance that came in below consensus, and CRO turnover that signals sales-execution risk. The vote count: 38% Strong Buy, 47% Buy, 16% Hold, 0% Sell among analysts covering MDB stock.
When is the next MDB stock earnings report?
MongoDB reports Q1 FY27 results after market close on Thursday, May 28, 2026, covering the three months ended April 30, 2026. Consensus expects roughly $553.6M in revenue and $0.66 in adjusted EPS. Options markets are pricing a ±14.5% post-print move, the widest implied move MDB stock has carried into a report in two years.
What is MongoDB’s analyst price target for 2026?
The consensus 12-month MDB stock price target sits at $368.67 across 33 analysts, with a high of $500 and a low of $260. The Simply Wall St narrative-based fair value is $440 (26% above the current price), and DCF aggregations cluster in the $350–$400 zone. Both methodologies imply the market has overcorrected for the March guidance miss.
Why did MDB stock fall so sharply in March 2026?
MDB stock fell roughly 22% in a single session on March 3, 2026 after Q4 FY26 results beat on revenue and EPS but came paired with cautious FY27 guidance. Investors interpreted the outlook as a signal that Atlas growth was decelerating into a tougher comparison year, and the move was amplified by Baird’s same-day downgrade from $500 to $260. The stock has since recovered 28% off the lows as bottom-fishing buyers re-engaged ahead of the May 28 print.
Disclaimer
This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Past performance does not guarantee future results. Investors should conduct thorough due diligence and consult qualified financial advisors before making investment decisions.
MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero trading fees, while prioritizing a secure, user-friendly, and accessible trading experience. Select MEXC as Your 0-fee Gateway To Infinite Opportunities.